ALKERMES | ALKS - 流动资产

金融业

USD 45.34

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.34B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	流动资产	更改		日
AbbVie	USD 33.67B		140M	2026-06
Acadia Pharmaceuticals	USD 1.22B		128.53M	2026-06
ALKERMES	USD 1.52B		164.26M	2026-06
Amgen	USD 34.96B		3.49B	2026-06
Biogen	USD 7.58B		278.7M	2026-09
BioMarin Pharmaceutical	USD 3.97B		633.45M	2026-06
Bristol-Myers Squibb	USD 29.77B		1.19B	2026-09
Coherus Biosciences	USD 133.79M		72.25M	2026-06
Eli Lilly	USD 65.26B		591M	2026-09
Gilead Sciences	USD 16.55B		4.02B	2026-09
Heron Therapeutics	USD 229.84M		861K	2026-06
Ionis Pharmaceuticals	USD 2.49B		446.73M	2026-06
J&J	USD 56.35B		3.42B	2026-09
Malin Corporation	EUR 62.6M		26.7M	2024-12
Merck	USD 36.68B		1.66B	2026-06
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Nektar Therapeutics	USD 589.04M		322.77M	2026-03
Neurocrine Biosciences	USD 1.64B		798.6M	2026-06
Otsuka Holdings	JPY 1.63T		30.58B	2026-06
Ovoca Bio	EUR 2.07M		510K	2025-12
Pfizer	USD 41.36B		1.46B	2026-06
Regeneron Pharmaceuticals	USD 20.8B		2.35B	2026-09
Vertex Pharmaceuticals	USD 12.54B		813.4M	2026-06